Kymera Therapeutics Inc (KYMR)

EBITDA

-$291.43M

TTM · Period ending: · USD

KYMR logo

KYMR EBITDA

Latest reported-$291.43M
KYMR EBITDA (-$21.25M → -$291.43M)
High-resolution chart · PNG

KYMR ebitda history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
-303,061,000
-216,236,000
-143,201,000
-151,655,000
-97,645,000
-43,715,000
-40,375,000
-21,246,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.